Chemed Corporation will release Q4 2025 financial results on February 25, 2026, followed by a conference call.
Quiver AI Summary
Chemed Corporation announced that it will release its financial results for the fourth quarter ending December 31, 2025, on February 25, 2026, after the market closes. A conference call and webcast will be held the following day at 10 a.m. ET to discuss these results and provide a business update. Participants can access the live webcast on Chemed’s investor relations website or register for a teleconference to receive dial-in details. A replay of the conference call will be made available shortly after it concludes. Chemed, headquartered in Cincinnati, operates VITAS Healthcare, the largest hospice care provider in the U.S., and Roto-Rooter, a leading plumbing service. The press release includes forward-looking statements, with a caution that actual results may vary.
Potential Positives
- Chemed Corporation will announce its fourth-quarter financial results, indicating ongoing transparency and communication with stakeholders.
- The scheduled conference call and webcast provide an opportunity for investors to directly engage with the company's leadership and gain insights into its business performance.
- Chemed's dual subsidiary model, with VITAS Healthcare being the largest provider of hospice care and Roto-Rooter leading in plumbing services, underscores the company's diverse revenue streams and strong market positions.
Potential Negatives
- Announcement of financial results on February 25, 2026, may indicate delays or uncertainty in timely reporting, which could be a concern for investors.
- The mention of forward-looking statements being subject to inherent risk may highlight potential instability or unpredictability in the company's future performance.
FAQ
When will Chemed Corporation announce its fourth quarter financial results?
Chemed Corporation will release its fourth quarter financial results on February 25, 2026.
What time is the Chemed Corporation conference call?
The conference call is scheduled for 10 a.m. ET on February 26, 2026.
How can I access the Chemed conference call?
You can access the conference call via webcast through Chemed's investor relations website or by registering for the teleconference.
Will there be a replay of the conference call?
Yes, a taped replay will be available approximately two hours after the call concludes.
What services does Chemed Corporation provide?
Chemed Corporation operates VITAS Healthcare for hospice care and Roto-Rooter for plumbing services.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CHE Insider Trading Activity
$CHE insiders have traded $CHE stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $CHE stock by insiders over the last 6 months:
- NICHOLAS MICHAEL WESTFALL (Executive Vice President) sold 10,012 shares for an estimated $4,224,162
- KEVIN J MCNAMARA (president and CEO) has made 0 purchases and 3 sales selling 7,000 shares for an estimated $3,116,040.
- GEORGE J III WALSH purchased 200 shares for an estimated $83,420
- PATRICK P GRACE sold 150 shares for an estimated $69,508
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CHE Revenue
$CHE had revenues of $624.9M in Q3 2025. This is an increase of 3.09% from the same period in the prior year.
You can track CHE financials on Quiver Quantitative's CHE stock page.
$CHE Hedge Fund Activity
We have seen 262 institutional investors add shares of $CHE stock to their portfolio, and 272 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 275,423 shares (+122.7%) to their portfolio in Q3 2025, for an estimated $123,317,894
- FMR LLC removed 103,005 shares (-54.6%) from their portfolio in Q3 2025, for an estimated $46,119,458
- SCHRODER INVESTMENT MANAGEMENT GROUP removed 86,625 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $38,785,477
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 84,208 shares (+740.9%) to their portfolio in Q3 2025, for an estimated $37,703,289
- EPOCH INVESTMENT PARTNERS, INC. added 69,878 shares (+29.4%) to their portfolio in Q3 2025, for an estimated $31,287,175
- VANGUARD GROUP INC removed 64,084 shares (-4.0%) from their portfolio in Q3 2025, for an estimated $28,692,970
- UBS GROUP AG added 57,201 shares (+104.2%) to their portfolio in Q3 2025, for an estimated $25,611,175
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CHE Analyst Ratings
Wall Street analysts have issued reports on $CHE in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 11/10/2025
- B of A Securities issued a "Buy" rating on 09/10/2025
- Jefferies issued a "Buy" rating on 09/02/2025
- Oppenheimer issued a "Outperform" rating on 07/31/2025
To track analyst ratings and price targets for $CHE, check out Quiver Quantitative's $CHE forecast page.
$CHE Price Targets
Multiple analysts have issued price targets for $CHE recently. We have seen 4 analysts offer price targets for $CHE in the last 6 months, with a median target of $576.0.
Here are some recent targets:
- Ben Hendrix from RBC Capital set a target price of $572.0 on 11/10/2025
- Joanna Gajuk from B of A Securities set a target price of $595.0 on 09/10/2025
- Brian Tanquilut from Jefferies set a target price of $550.0 on 09/02/2025
- Michael Wiederhorn from Oppenheimer set a target price of $580.0 on 07/31/2025
Full Release
CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange.
Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 26, 2026, to discuss the company's quarterly results and to provide an update on its business.
Participants may access a live webcast of the conference call through the investor relations section of Chemed’s website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/srzsz65g .
Participants may also register via teleconference at https://register-conf.media-server.com/register/BIe4160b0d86fb4a3cb11588d64e00d9e7 .
Once registration is completed, participants will be provided with a dial-in number containing a personalized conference code to access the call. All participants are instructed to dial-in 15 minutes prior to the start time.
A taped replay of the conference call will be available beginning approximately two hours after the call's conclusion. You may access the replay via webcast through the investor relations section of Chemed’s website.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
CONTACT:
Michael D. Witzeman
(513) 762-6714
